Neurological presentations of lysosomal diseases in adult patients;Présentations neurologiques des maladies lysosomales chez l'adulte

Revue Neurologique

Volumn 163, Issue 10, 2007, Pages 919-929

  Sedel, F ^a,b   Turpin, J C ^a   Baumann, N ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Adult onset; Hereditary metabolic diseases; Inborn errors of metabolism; Leukodystrophy; Lysosome

Indexed keywords

AGALSIDASE ALFA; AGALSIDASE BETA; LARONIDASE; MIGLUSTAT;

ABDOMEN; BETA MANNOSIDOSIS; BRAIN; CLINICAL EXAMINATION; CLINICAL FEATURE; ECHOGRAPHY; ELECTRODIAGNOSIS; FABRY DISEASE; FUCOSIDOSIS; GAUCHER DISEASE; GLOBOID CELL LEUKODYSTROPHY; GM1 GANGLIOSIDOSIS; GM2 GANGLIOSIDOSIS; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; KANZAKI DISEASE; LIPOFUSCINOSIS; LYSOSOME STORAGE DISEASE; MANNOSIDOSIS; METACHROMATIC LEUKODYSTROPHY; MUCOPOLYSACCHARIDOSIS; NEUROLOGIC DISEASE; NEUROLOGY; NIEMANN PICK DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHIATRIC DEPARTMENT; REVIEW; SANFILIPPO SYNDROME; SCHINDLER DISEASE; SIALIC ACID STORAGE DISEASE; SIALIDOSIS; TYPE 1 SIALIDOSIS;

EID: 36248940837     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)92635-1     Document Type: Article

References (60)

1. BACH G. (2001). Mucolipidosis type IV. Mol Genet Metab, 73: 197-203.
2. BAJAJ NPS, WALDMANN A, ORRELL B, WOOD NW, BHATIA KP. (2002). Familial adult onset of Krabbe's disease resembling hereditary spastic paraplegia with normal neuroimaging. J Neurol Neurosurg Psychiatry, 72: 635-638.
3. BATAILLARD M, RICHARD P, RUMBACH L, VANIER MT, TRUTTMANN M. (1997). Isolated spastic paraparesis disclosing Krabbe disease in adult age. Rev Neurol (Paris), 153: 347-350.
4. BAUMANN N, MASSON M, CARREAU V, LEFEVRE M, HERSCKOWITZ N, TURPIN JC. (1991). Adult forms of metachromatic leukodystrophy: clinical and biochemical approach. Dev Neurosci, 13: 211-215.
5. BERGER-PLANTINGA EG, VANNESTE JA, GROENER JE, VAN SCHOONEVELD MJ. (2004). Adult-onset dementia and retinitis pigmentosa due to mucopolysaccharidosis III-C in two sisters. J Neurol, 251: 479-481.
6. BERKOVIC SF, CARPENTER S, ANDERMANN F, ANDERMANN E, WOLFE LS. (1988). Kufs' disease: a critical reappraisal. Brain, 111: 27-62.
7. BOSCH EP, HART MN. (1978). Late adult-onset metachromatic leucodystrophy. Dementia and polyneuropathy in a 63 yea-old-man. Arch Neurol, 35: 475-477.
8. CHERIN P, SEDEL F, MIGNOT C, SCHUPBACH M, GOURFINKEL-AN I, VERNY M, BAUMANN N. (2006). Neurological manifestations of type 1 Gaucher's disease: is a revision of disease classification needed? Rev Neurol (Paris), 162: 1076-1083.
9. DESNICK RJ, BRADY R, BARRANGER J et al. (2003). Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med, 138: 338-346.
10. DUBOIS G, TURPIN JC, BAUMANN N. (1975). Absence of ASA activity in healthy father of a patient with metachromatic leukodystrophy. N Engl J Med, 293: 302.
11. FARINA L, BIZZI A, FINOCCHIARO G et al. (2000). MR imaging and proton MR Spectroscopy in adult Krabbe disease. Am J Neuroradiol, 21: 1478-1482.
12. FEDERICO A, BATTISTINI S, CIACCI G, DE STEFANO N, GATTI R, DURAND P, GUAZZI GC. (1991). Cherry-red spot myoclonus syndrome (type I sialidosis). Dev Neurosci, 13: 320-326.
13. FONTAINE B, THENIN JP, VIADER F. (2003). Gait disorders with insidious progression in a 60-year old woman. Rev Neurol (Paris), 159: 695-699.
14. FREI KP, PATRONAS NJ, CRUTCHFIELD KE, ALTARESCU G, SCHIFFMANN R. (1998). Mucolipidosis type IV: characteristic MRI findings. Neurology, 51: 565-569.
15. FRESSINAUD C, VALLAT JM, MASSON M, JAUBERTEAU MO, BAUMANN N, HUGON J. (1992). Adult-onset metachromatic leukodystrophy presenting as isolated peripheral neuropathy. Neurology, 42: 1396-1398.
16. GORT L, DUQUE J, FABEIRO JM, ZULAICA A, COLL MJ, CHABAS A. (2006). Molecular analysis in two beta-mannosidosis patients: Description of a new adult case. Mol Genet Metab, 89: 398-400.
17. GREWAL SS, SHAPIRO EG, KRIVIT W et al. (2004). Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation. J Pediatr, 144: 569-573.
18. GUIMARAES J, AMARAL O, SA MIRANDA MC. (2003). Adult-onset neuronopathic form of Gaucher's disease: a case report. Parkinsonism Relat Disord, 9: 261-264.
19. GUTSCHALK A, HARTING I, CANTZ M, SPRINGER C, ROHRSCHNEIDER K, MEINCK HM. (2004). Adult alpha-mannosidosis: clinical progression in the absence of demyelination. Neurology, 63:1744-1746.
20. HALTIA M. (2003). The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol, 62: 1-13.
21. HENDERSON RD, MACMILLAN JC, BRADFIELD JM. (2003). Adult onset Krabbe disease may mimic motor neurone disease. J Clin Neurosci, 10: 638-639.
22. IKEDA S, KONDO K, OGUCHI K, YANAGISAWA N, HORIGOME R, MURATA F (1984). Adult fucosidosis: histochemical and ultrastructural studies of rectal mucosa biopsy. Neurology, 34: 451-456.
23. KHAN SA, SEHAT K, CALTHORPE D (2003). Cervical cord compression in an elderly patient with Hurler's syndrome: a case report. Spine, 28: E313-E315.
24. KIDD D, NELSON J, JONES F, DUSOIR H, WALLACE I, MCKINSTRY S, PATTERSON V. (1998). Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol, 55: 98-99.
25. KING JO. (1975). Progressive myoclonic epilepsy due to Gaucher's disease in an adult. J Neurol Neurosurg Psychiatry, 38: 849-854.
26. KRIVIT W, SHAPIRO EG, PETERS C et al. (1998). Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med, 338: 1119-1126.
27. LEVADE T, GRABER D, FLURIN V et al. (1994). Human beta-mannosidase deficiency associated with peripheral neuropathy. Ann Neurol, 35: 116-119.
28. MALM D, PANTEL J, LINAKER OM. (2005). Psychiatric symptoms in alpha-mannosidosis. J Intellect Disabil, Res 49: 865-871.
29. MARCÃO A, WIEST R, SCHINDLER K et al. (2005). Adult onset metachromatic leukodystrophy without electroclinical peripheral nervous system involvement. Arch Neurol 62: 309-313.
30. MITSIAS P, LEVINE SR (1996). Cerebrovascular complications of Fabry's disease. Ann Neurol, 40: 8-17.
31. MOLE SE, WILLIAMS RE, GOEBEL HH. (2005). Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics, 6: 107-126.
32. MOORE DF, YE F, SCHIFFMANN R, BUTMAN JA. (2003). Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol, 24: 1096-1101.
33. MUTHANE U, CHICKABASAVIAH Y, KANESKI C, SHANKAR SK, NARAYANAPPA G, CHRISTOPHER R, GOVINDAPPA SS. (2004). Clinical features of adult GM1 gangliosidosis: report of three Indian patients and review of 40 cases. Mov Disord, 19: 1334-1341.
34. NAVON R. (1991). Molecular and clinical heterogeneity of adult GM2 gangliosidosis. Dev Neurosci, 13: 295-298.
35. NAVON R, KHOSRAVI R, MELKI J et al. (1997). Juvenile-onset spinal muscular atrophy caused by compound heterozygosity for mutations in the HEXA gene. Ann Neurol, 41: 631-638.
36. NEUDORFER O, PASTORES GM, ZENG BJ, GIANUTSOS J, ZAROFF CM, KOLODNY EH. (2005). Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients. Genet Med, 7: 119-123.
37. NIEMANN S, BECK M, SEIDEL G, SPRANGER J, VIEREGGE P. (1996). Neurology of adult alpha-mannosidosis. J Neurol Neurosurg Psychiatry, 61: 116-117.
38. OBENBERGER J, SEIDL Z, PAVLU H, ELLEDER M. (1999). MRI in an unusually protracted neuronopathic variant of acid sphingomyelinase deficiency. Neuroradiology, 41:182-184.
39. RAUSCHKA H, COLSCH B, BAUMANN N et al. (2006). Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology, 67: 859-863.
40. REIS S, SHEFFER RN, MERIN S, LUDER AS, BACH G. (1993). Mucolipidosis type IV: a mild form with late onset. Am J Med Genet, 47: 392-394.
41. RUCKER JC, SHAPIRO BE, HAN YH, KUMAR AN, GARBUTT S, KELLER EL, LEIGH RJ. (2004). Neuro-ophthalmology of late-onset Tay-Sachs disease (LOTS). Neurology, 63: 1918-1926.
42. ROLFS A, BOTTCHER T, ZSCHIESCHE M et al. (2005). Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet, 366: 1794-1796.
43. ROZE E, PASCHKE E, LOPEZ N et al. (2005) Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Mov Disord, 20: 1366-1369.
44. SABATELLI M, QUARANTA L, MADIA F et al. (2002). Peripheral neuropathy with hypomyelinating features in adult-onset Krabbe's disease. Neuromuscul Disord, 12: 386-391.
45. SEDEL F, FRIDERICI K, NUMMY K et al. (2006). Atypical Gilles de la Tourette Syndrome with beta-mannosidase deficiency. Arch Neurol, 63: 129-131.
46. SEVIN M, LESCA G, BAUMANN N, MILLAT G, LYON-CAEN O, VANIER MT, SEDEL F. (2007). The adult form of Niemann-Pick disease type C. Brain, 130: 120-133.
47. STEINMAN L, THARP BR, DORFMAN LJ et al. (1980). Peripheral neuropathy in the cherry-red spot-myoclonus syndrome (sialidosis type I). Ann Neurol, 7: 450-456.
48. UMEHARA F, MATSUMURO K, KURONO Y, ARIMURA K, OSAME M, KANZAKI T. (2004). Neurologic manifestations of Kanzaki disease. Neurology, 62: 1604-1606.
49. VAN DIGGELEN OP, THOBOIS S, TILIKETE C et al. (2001). Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase deficiency: first adult-onset patients of a childhood disease. Ann Neurol, 50: 269-272.
50. VAN SCHROJENSTEIN-DE VALK HM, VAN DE KAMP JJ. (1987). Follow-up on seven adult patients with mild Sanfilippo B-disease. Am J Med Genet, 28: 125-129.
51. VANIER MT, MILLAT G. (2003). Niemann-Pick disease type C. Clin Genet, 64: 269-281.
52. VARHO T, JAASKELAINEN S, TOLONEN U, SONNINEN P, VAINIONPAA L, AULA P, SILLANPAA M. (2000). Central and peripheral nervous system dysfunction in the clinical variation of Salla disease. Neurology, 55: 99-104.
53. VINCHON M, COTTEN A, CLARISSE J, CHIKI R, CHRISTIAENS JL. (1995). Cervical myelopathy secondary to Hunter syndrome in an adult. AJNR Am J Neuroradiol, 16: 1402-1403.
54. WASSERSTEIN MP, ARON A, BRODIE SE, SIMONARO C, DESNICK RJ, MCGOVERN MM. (2006). Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease. J Pediatr, 149: 554-559.
55. WENGER DA, SUZUKI K, SUZUKI Y, SUZUKI K. (2001). Galactosylceramide lipidosis: globoïd cell leukodystrophy (Krabbe disease). In Scriver CR, Beaudet AL, Sly WS, Valle D (eds.), The metabolic and molecular bases of inherited diseases. p. 3669-94. McGraw Hill. New York.
56. WENGER DA, COPPOLA S, LIU SL. (2003). Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol, 60: 322-328.
57. WINKELMAN MD, BANKER BQ, VICTOR M, MOSER HW. (1983). Noninfantile neuronopathic Gaucher's disease: a clinicopathologic study. Neurology, 33 : 994-1008.
58. WONG K, SIDRANSKY E, VERMA A et al. (2004). Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab, 82: 192-207.
59. YOSHIDA K, OSHIMA A, SAKURABA H et al. (1992). GM1 gangliosidosis in adults: clinical and molecular analysis of 16 Japanese patients. Ann Neurol, 31: 328-332.
60. ZAROFF CM, NEUDORFER O, MORRISON C, PASTORES GM, RUBIN H, KOLODNY EH. (2004). Neuropsychological assessment of patients with late onset GM2 gangliosidosis. Neurology, 62: 2283-2286.